UC2288 is primarily investigated for its potential applications in cancer research, particularly as a modulator of p53 activity. It is studied for its ability to enhance the tumor-suppressing functions of p53, a protein crucial for regulating cell division and preventing tumor formation. Researchers are exploring its use in developing therapies for cancers where p53 is mutated or dysfunctional. Additionally, UC2288 is being examined for its role in sensitizing cancer cells to chemotherapy and radiation, potentially improving treatment outcomes. Its application extends to studying cellular stress responses and apoptosis mechanisms, contributing to a deeper understanding of cancer biology and therapeutic strategies.